Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 241

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

Open access
Hu, William T., Holtzman, David M., Fagan, Anne M., Shaw, Leslie M., Perrin, Richard, Arnold, Steven E., Grossman, Murray, Xiong, Chengjie, Craig-Schapiro, Rebecca, Clark, Christopher M., Pickering, Eve, Kuhn, Max, Chen, Yu, Van Deerlin, Vivianna M., McCluskey, Leo, Elman, Lauren, Karlawish, Jason, Chen-Plotkin, Alice, Hurtig, Howard I., Siderowf, Andrew, Swenson, Frank, Lee, Virginia M.-Y., Morris, John C., Trojanowski, John Q., Soares, Holly·2012·Neurology

Abstract

OBJECTIVES: While plasma biomarkers have been proposed to aid in the clinical diagnosis of Alzheimer disease (AD), few biomarkers have been validated in independent patient cohorts. Here we aim to determine plasma biomarkers associated with AD in 2 independent cohorts and validate the findings in the multicenter Alzheimer's Disease Neuroimaging Initiative (ADNI). METHODS: Using a targeted proteomic approach, we measured levels of 190 plasma proteins and peptides in 600 participants from 2 independent centers (University of Pennsylvania, Philadelphia; Washington University, St. Louis, MO), and identified 17 analytes associated with the diagnosis of very mild dementia/mild cognitive impairment (MCI) or AD. Four analytes (apoE, B-type natriuretic peptide, C-reactive protein, pancreatic polypeptide) were also found to be altered in clinical MCI/AD in the ADNI cohort (n = 566). Regression analysis showed CSF Aβ42 levels and t-tau/Aβ42 ratios to correlate with the number of APOE4 alleles and plasma levels of B-type natriuretic peptide and pancreatic polypeptide. CONCLUSION: Four plasma analytes were consistently associated with the diagnosis of very mild dementia/MCI/AD in 3 independent clinical cohorts. These plasma biomarkers may predict underlying AD through their association with CSF AD biomarkers, and the association between plasma and CSF amyloid biomarkers needs to be confirmed in a prospective study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e318266fa70

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 241

Metadata

Authors
Hu, W. T., Holtzman, D. M., Fagan, A. M., Shaw, L. M., Perrin, R., Arnold, S. E., Grossman, M., Xiong, C., Craig-Schapiro, R., Clark, C. M., Pickering, E., Kuhn, M., Chen, Y., Van Deerlin, V. M., McCluskey, L., Elman, L., Karlawish, J., Chen-Plotkin, A., Hurtig, H. I., Siderowf, A., Swenson, F., Lee, V. M.-Y., Morris, J. C., Trojanowski, J. Q., & Soares, H.
Venue
Neurology
Published
2012-08-28
Volume
79
Issue
9
Pages
897-905
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2105181416
Cited by
241
References
12
FWCI
19.06
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. https://app.cochat.ai/papers/10.1212/wnl.0b013e318266fa70
The paper
Hu, W. T., Holtzman, D. M., Fagan, A. M., Shaw, L. M., Perrin, R., Arnold, S. E., Grossman, M., Xiong, C., Craig-Schapiro, R., Clark, C. M., Pickering, E., Kuhn, M., Chen, Y., Van Deerlin, V. M., McCluskey, L., Elman, L., Karlawish, J., Chen-Plotkin, A., Hurtig, H. I., . . . Soares, H. (2012). Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology. https://doi.org/10.1212/wnl.0b013e318266fa70

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.